Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve audited financial result ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd has informed BSE that a Board Meeting is scheduled for May 25, 2026 at 4:00 PM at the company's registered office in Mumbai. The meeting will consider and approve the Audited Financial Statement for the half year and full year ended March 31, 2026, along with the Auditor's Report. This is a standard regulatory filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing is a routine notice and does not contain any actual financial results or performance data. The actual financial performance will be disclosed after the board meeting concludes.
This is a routine meeting notice; no direct impact on shareholders until results are announced. Once approved, the audited financial results could trigger price movement depending on whether performance meets, beats, or misses market expectations.